These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 68276)

  • 1. Type-III Hyperlipoproteinaemia ("remnant removal disease"). Insight into the pathogenetic mechanism.
    Chait A; Brunzell JD; Albers JJ; Hazzard WR
    Lancet; 1977 Jun; 1(8023):1176-8. PubMed ID: 68276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The metabolism of low density lipoprotein in endogenous hypertriglyceridaemia.
    Sigurdsson G; Nicoll A; Lewis B
    Eur J Clin Invest; 1976 Mar; 6(2):151-8. PubMed ID: 177294
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Catabolism of very low density lipoprotein B apoprotein in man.
    Reardon MF; Fidge NH; Nestel PJ
    J Clin Invest; 1978 Mar; 61(3):850-60. PubMed ID: 205554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural oestrogen as an effective treatment for type-II hyperlipoproteinaemia in postmenopausal women.
    Tikkanen MJ; Nikkila EA; Vartiainen E
    Lancet; 1978 Sep; 2(8088):490-1. PubMed ID: 79863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipoprotein distribution of apolipoprotein C-III and its relationship to the presence in plasma of triglyceride-rich remnant lipoproteins.
    Marcoux C; Tremblay M; Fredenrich A; Davignon J; Cohn JS
    Metabolism; 2001 Jan; 50(1):112-9. PubMed ID: 11172484
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conversion of very low density lipoprotein to low density lipoprotein. A metabolic study of apolipoprotein B kinetics in human subjects.
    Sigurdsson G; Nicoll A; Lewis B
    J Clin Invest; 1975 Dec; 56(6):1481-90. PubMed ID: 172533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conversion of the electrophoretic pattern of type IV hyperlipidaemia to type III by intravenous heparin.
    Olsson AG; Carlson LA; Carlson K
    Acta Med Scand; 1978; 203(6):487-90. PubMed ID: 208351
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of 75Se-selenomethionine into human apoproteins. III. Kinetic behavior of isotopically labeled plasma apoprotein in man.
    Eaton RP; Crespin S; Kipnis DM
    Diabetes; 1976 Aug; 25(8):679-90. PubMed ID: 182607
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peripheral vascular disease in cigarette smokers and impaired hepatic metabolism of lipoprotein remnants.
    Topping DL; Dwyer T; Weller RA
    Lancet; 1977 Dec 24-31; 2(8052-8053):1327-8. PubMed ID: 74734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
    Vessby B; Hedstrand H; Olsson U
    Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of behaviour of very low density lipoproteins of type III hyperlipoproteinaemia on electrophoresis on paper and on agarose gel with a note on a late (slow) pre-beta VLDL liproprotein.
    Carlson K; Carlson LA
    Scand J Clin Lab Invest; 1975 Nov; 35(7):655-60. PubMed ID: 174185
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
    Olsson AG; Rössner S; Walldius G; Carlson LA
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural peculiarities of the binding of very low density lipoproteins and low density lipoproteins to the LDL receptor in hypertriglyceridemia: role of apolipoprotein E.
    Dergunov AD; Smirnova EA; Merched A; Visvikis S; Siest G; Yakushkin VV; Tsibulsky V
    Biochim Biophys Acta; 2000 Feb; 1484(1):29-40. PubMed ID: 10685028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gemfibrozil: effect on serum lipids, lipoproteins, postheparin plasma lipase activities and glucose tolerance in primary hypertriglyceridaemia.
    Nikkilä EA; Ylikahri R; Huttunen JK
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):58-63. PubMed ID: 190608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The spectrum of electrophoretic mobility of very low density lipoproteins: role of slower migrating species in endogenous hypertriglyceridemia (type IV hyperlipoproteinemia) and broad-beta disease (type III).
    Hazzard ER; Bierman EL
    J Lab Clin Med; 1975 Aug; 86(2):239-52. PubMed ID: 168277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-density lipoprotein metabolism in the nephrotic syndrome.
    Warwick GL; Caslake MJ; Boulton-Jones JM; Dagen M; Packard CJ; Shepherd J
    Metabolism; 1990 Feb; 39(2):187-92. PubMed ID: 2299990
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of 3-hydroxy-3-methylglutaryl-CoA reductase activity in cultured human fibroblasts by very low density lipoproteins of subjects with hypertriglyceridemia.
    Gianturco SH; Gotto AM; Jackson RL; Patsch JR; Sybers HD; Taunton OD; Yeshurun DL; Smith LC
    J Clin Invest; 1978 Feb; 61(2):320-8. PubMed ID: 202612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
    Ginsberg HN; Le NA; Gibson JC
    J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of action of a peroxisome proliferator-activated receptor (PPAR)-delta agonist on lipoprotein metabolism in dyslipidemic subjects with central obesity.
    Ooi EM; Watts GF; Sprecher DL; Chan DC; Barrett PH
    J Clin Endocrinol Metab; 2011 Oct; 96(10):E1568-76. PubMed ID: 21816786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of low dose oral contraceptives on very low density and low density lipoprotein metabolism.
    Walsh BW; Sacks FM
    J Clin Invest; 1993 May; 91(5):2126-32. PubMed ID: 8486779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.